|
|
- 2018
3.0T MR 表观弥散系数对慢性乙型肝炎肝纤维化程度的评估
|
Abstract:
摘要 目的： 探讨3.0T MR测定表观弥散系数(apparent diffusion coefficient,ADC)值评估慢性乙型病毒性肝炎(chronic hepatitis B,CHB)所致肝脏纤维化(liver fibrosis,LF)程度的价值.方法: 选取经肝脏穿刺活检确诊的CHB肝纤维化患者47例(其中S1期10例,S2期10例,S3期14例,S4期13例),经临床及影像学确诊的肝硬化患者(S5)14例及健康正常人(S0)10例,进行3.0T MR弥散加权成像(diffusion weighted imaging, DWI)检查;测量肝脏ADC值并计算其平均值.分析各组间ADC值的差异及其与LF程度、炎症程度的相关性;采用受试者工作特征曲线(ROC曲线)分析ADC值评估LF程度的能力.结果: LF程度与ADC值呈负性相关(R2=0.859,P=0.000),组间ADC值均有统计学差异(F=40.868,P<0.001),组内相互比较:S0与S2、S3、S4、S5之间,S1与S2、S3、S4、S5之间,S2与S0、S1、S3、S4、S5之间,S3与S0、S1、S2、S5之间,S4与S0、S1、S2之间,S5与S0、S1、S2、S3之间,组间具有统计学差异(P<0.05).S0、S1+S2(轻度LF)、S3+S4(重度LF)、S5组间差异有统计学意义(F=49.215,P<0.001),组内两两比较,均有统计学差异(P均<0.05).ROC曲线显示ADC值预测LF(S≥1,S≥3,S=5)有统计学意义(P=0.000);以ADC≤ 1.229诊断S≥1的敏感性为91.7%、特异性为88.5%,以ADC≤1.109诊断S≥3的敏感性为96.9%、特异性为90.2%,以ADC≤1.034诊断S=5的敏感性为81.4%、特异性为85.7%.结论: 无创、简便的DWI检查测量肝脏ADC值,可为临床评估CHB肝纤维化的程度提供重要依据.
| [1] | KIM S U,LEE J H,KIM D Y, et al.Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis[J].PLOS ONE,2012,7(5):e36676-36684. |
| [2] | HONG Y,SHI Y,LIAO W,et al.Relative ADC measurement for liver fibrosis diagnosis in chronic hepatitis B using spleen/renal cortex as the reference organs at 3T[J].Clinical Radiology, 2014,69(6): 581-588. |
| [3] | 陈鑫,刘玉品,池晓玲,等. 3.0T MR磁化传递成像评价慢性乙型肝炎肝纤维化[J].暨南大学学报(自然科学与医学版),2013,34(4):425-429. |
| [4] | CHEN X,LIU Y P,CHI X L, et al.Preliminary study of 3.0T MR magnetization transfer imaging in evaluating chronic hepatitis B fibrosis[J].Journal of Jinan University(Medicine Edition),2013, 34(4):425-429. |
| [5] | BACHIR T,ANUJ J T,MARIELA L,et al.Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience[J]. American Journal of Roentgenology,2007,189(4): 799-806. |
| [6] | SANDRASEGARAN K,TAHIR B,PATEL A,et al.The usefulness of diffusion-weighted imaging in the characterization of liver lesions in patients with cirrhosis[J]. Clinical Radiology,2013,68(7):708-715. |
| [7] | 周应媛,张继明.磁共振DWI对慢性乙型肝炎肝纤维化程度和活动度的评价[J].重庆医学,2015,44(14):1876-1878. |
| [8] | ZHOU Y Y,ZHANG J M.Evaluation of liver fibrosis degree and activity in chronich epatitis B by magnetic resonance diffusion weighted imaging[J]. Chongqing Medicine,2015,44(14):1876-1878. |
| [9] | PALMUCCI S, CAPPELLO G, AEEINAG,et al.Diffusion-weighted MRI for the assessment of liver fibrosis: principles and applications[J].Biomed Research International, 2015,3(19):874201-874208. |
| [10] | KERSHENOBICH S D, WEISSBORD S D.Liver fibrosis and inflammation. A review[J]. Annals of hepatology,2003,2(4):159-163. |
| [11] | MARCO V D, IACONO O L,CAMMA C, et al.The long-term course of chronic hepatitis B[J]. Hepatology, 1999,30(1):257-264. |
| [12] | FRIEDMAN S L.Hepatic fibrosis-overview[J].Toxicology,2008,254(3):120-129. |
| [13] | BRAVO A A,SHETH S G,CHOPRA S.Liver biopsy[J]. The New England journal of medicine,2001,344(7):495-500. |
| [14] | REGEV A, BERHO M, JEFFERS L J,et al.Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection[J]. The American journal of gastroenterology,2002,97(10):2614-2618. |
